Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions

Personalized Medicine
Katherine PayneEgbert Bakker

Abstract

Whole-genome sequencing (WGS) is being applied within research settings across Europe to develop genomic WGS-based diagnostic tests. The focus of this perspective paper is to describe if, and how, current approaches of health technology assessment could be applied to WGS-based diagnostic tests. This perspective draws on the collective view from a trans-European multidisciplinary consortium of methodologists, clinicians and scientists. Specific challenges can be described by using the PICO (population, intervention, comparator, outcome) framework to inform health technology assessment. Practical solutions are suggested which require joined-up, multidisciplinary working across healthcare systems using existing expert networks so that emergent issues for the health technology assessment of WGS can be met in a timely fashion.

References

May 5, 1998·Medical Decision Making : an International Journal of the Society for Medical Decision Making·D A AschM T Mennuti
Jan 29, 2002·Lancet·David A Grimes, Kenneth F Schulz
Jun 11, 2002·International Journal of Technology Assessment in Health Care·Marcial VelascoClaudia Wild
Jul 17, 2003·International Journal of Technology Assessment in Health Care·Mita GiacominiGeorge Browman
Oct 16, 2003·Community Genetics·Mita GiacominiBernie J O'Brien
Oct 26, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Josh J CarlsonScott D Ramsey
Jun 16, 2006·Applied Health Economics and Health Policy·James Jarrett, Miranda Mugford
Aug 31, 2006·Health Economics·Alan BrennanRuth Davies
Sep 21, 2006·International Journal of Technology Assessment in Health Care·Wolf Rogowski
Nov 16, 2007·Fertility and Sterility·Jennifer E MersereauMarcelle I Cedars
Oct 1, 2008·BMJ : British Medical Journal·Peter CraigUNKNOWN Medical Research Council Guidance
Jun 19, 2009·Medical Care·Kevin D Frick
Oct 13, 2009·Health Economics·Katherine Payne
Mar 20, 2010·European Heart Journal·Sarah WordsworthHugh Watkins
Jan 29, 2011·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sandjar DjalalovJeffrey Hoch
May 21, 2011·The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care·Fernando AntoñanzasM Pinillos
Sep 1, 2011·Rheumatology·Jonathan ToshNick Bansback
May 15, 2012·Journal of Medical Genetics·James O'SullivanGraeme C Black
Sep 20, 2012·Medical Decision Making : an International Journal of the Society for Medical Decision Making·J Jaime CaroUNKNOWN ISPOR-SMDM Modeling Good Research Practices Task Force
Sep 27, 2012·Genetic Testing and Molecular Biomarkers·Nazila AssasiFeng Xie
Oct 26, 2012·Health Expectations : an International Journal of Public Participation in Health Care and Health Policy·Gavin Daker-WhiteCaroline Sanders
Feb 14, 2013·European Journal of Human Genetics : EJHG·Ryan CombsGeorgina Hall
May 17, 2013·European Journal of Human Genetics : EJHG·Carla G van ElUNKNOWN ESHG Public and Professional Policy Committee
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Lieven AnnemansKatherine Payne
Sep 27, 2013·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Katherine Payne, Lieven Annemans
Nov 15, 2013·Clinical Chemistry·Caitlin C Chrystoja, Eleftherios P Diamandis
Nov 19, 2013·Pharmacogenomics·James BuchananAnna Schuh
Dec 18, 2013·Health Economics Review·Martin FrankJ-Matthias Graf von der Schulenburg
Jun 5, 2014·Nature·Christian GilissenJoris A Veltman
Aug 12, 2014·Expert Review of Molecular Diagnostics·Felix W Frueh, Bruce Quinn
May 23, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Michael P DouglasKathryn A Phillips
Jun 25, 2015·Human Genomics·Andrew MallettHelen Healy
Aug 1, 2015·Genome Medicine·Stephen F KingsmoreErin Guest
Nov 26, 2015·European Journal of Human Genetics : EJHG·Katia HardiesArvid Suls
Jul 9, 2016·Journal of Diabetes·Martine Vaxillaire, Philippe Froguel
Sep 28, 2016·Public Health Genomics·Athanassios VozikisGeorge P Patrinos

❮ Previous
Next ❯

Citations

Apr 24, 2018·Expert Review of Precision Medicine and Drug Development·Sean P GavanKatherine Payne
Jan 23, 2018·Nature Reviews. Genetics·Katherine PayneAlexander J Thompson
Jul 14, 2018·PharmacoEconomics·James Love-KohMatthew Taylor
Dec 16, 2020·NPJ Genomic Medicine·Robin Z HayeemsUNKNOWN Medical Genome Initiative
Apr 30, 2021·Expert Review of Pharmacoeconomics & Outcomes Research·Martijn SimonsValesca Retèl
May 12, 2020·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Eric FaulknerKatherine Payne

❮ Previous
Next ❯

Software Mentioned

TEST
3Gb

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The Veterinary Record
Mariette Jose Asselbergs
Health Services Journal
Matt Fossey, Laurie Bryant
American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists
Thane Kreiner, Katie Tillman Buck
© 2022 Meta ULC. All rights reserved